451 related articles for article (PubMed ID: 30443908)
1. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.
Romphruk AV; Simtong P; Butryojantho C; Pimphumee R; Junta N; Srichai S; Komvilaisak P; Puapairoj C
Transfusion; 2019 Jan; 59(1):177-184. PubMed ID: 30443908
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
3. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
[TBL] [Abstract][Full Text] [Related]
4. RBC alloimmunization and double alloantibodies in thalassemic patients.
Azarkeivan A; Ahmadi MH; Zolfaghari S; Shaiegan M; Ferdowsi S; Rezaei N; Lotfi P
Hematology; 2015 May; 20(4):223-7. PubMed ID: 25130935
[TBL] [Abstract][Full Text] [Related]
5. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.
Singer ST; Wu V; Mignacca R; Kuypers FA; Morel P; Vichinsky EP
Blood; 2000 Nov; 96(10):3369-73. PubMed ID: 11071629
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
Thedsawad A; Taka O; Wanachiwanawin W
Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
[TBL] [Abstract][Full Text] [Related]
7. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
[TBL] [Abstract][Full Text] [Related]
9. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
Ang AL; Lim CY; Ng WY; Lam JCM
Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.
Teawtrakul N; Songdej D; Hantaweepant C; Tantiworawit A; Lauhasurayotin S; Torcharus K; Sripornsawan P; Sutcharitchan P; Surapolchai P; Komvilaisak P; Saengboon S; Pongtanakul B; Charoenkwan P;
Transfusion; 2022 Oct; 62(10):2039-2047. PubMed ID: 35986658
[TBL] [Abstract][Full Text] [Related]
11. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
[TBL] [Abstract][Full Text] [Related]
12. Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
Al-Riyami AZ; Al-Muqbali A; Al-Sudiri S; Murthi Panchatcharam S; Zacharia M; Al-Mahrooqi S; Al-Hosni S; Al-Marhoobi A; Daar S
Transfusion; 2018 Apr; 58(4):871-878. PubMed ID: 29399805
[TBL] [Abstract][Full Text] [Related]
13. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.
Al-Mousawi MM; Al-Allawi NA; Alnaqshabandi R
Hemoglobin; 2015; 39(6):423-6. PubMed ID: 26327166
[TBL] [Abstract][Full Text] [Related]
15. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
Cheng CK; Lee CK; Lin CK
Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
[TBL] [Abstract][Full Text] [Related]
16. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients.
Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS
J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization in transfused patients with constitutional anemias in Norway.
Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
[TBL] [Abstract][Full Text] [Related]
18. Frequency of red cell allo- and autoimmunization in patients with transfusion-dependent beta thalassemia and affecting factors.
Koçyiğit C; Eliaçık K; Kanık A; Atabay B; Türker M
Turk J Pediatr; 2014; 56(5):487-92. PubMed ID: 26022583
[TBL] [Abstract][Full Text] [Related]
19. Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.
Poornima AP; Fazal S; Shaiji PS; Usha KC; Kailas L
Indian J Pediatr; 2019 Mar; 86(3):245-249. PubMed ID: 30515703
[TBL] [Abstract][Full Text] [Related]
20. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
